Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): Structure–activity relationships and strategies for the elimination of reactive metabolite formation

Daniel P. Walker, F. Christopher Bi, Amit S. Kalgutkar, Jonathan Bauman, Sabrina X. Zhao, John R. Soglia, Gary E. Aspnes, Daniel W. Kung, Jacquelyn Klug‐McLeod, Michael P. Zawistoski,

Bioorganic & Medicinal Chemistry Letters · 2008 · 53 citations · 9 references

DOIFull text

Open access

Concepts

References

9